Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 9 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $3.5M (52,486 shares) of Cytokinetics Inc on Dec 5, 2025. Filing
- Last sale before this period: Jun 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | EVP, Chief Commercial Officer | Apr 5, 2021 | Aug 31, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Cytokinetics Inc: sold 10,000 shares for $702K, under a disclosed plan; 10,000 shares acquired by exercising options. 1 filing: 1
- Jul 30, 2026, Cytokinetics Inc: sold 14,000 shares for $1.1M, under a disclosed plan; 14,000 shares acquired by exercising options. 1 filing: 1
- Jul 1, 2026, Cytokinetics Inc: sold 15,000 shares for $1.3M, under a disclosed plan; 15,000 shares acquired by exercising options. 1 filing: 1
- Jun 1, 2026, Cytokinetics Inc: sold 15,000 shares for $1.1M, under a disclosed plan; 15,000 shares acquired by exercising options. 1 filing: 1
- May 5, 2026, Cytokinetics Inc: sold 11,333 shares for $875K, under a disclosed plan; 11,333 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.